These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Growth control in mouse Y-1 adrenocortical tumor cells: role of c-Ki-ras amplification and effects of ACTH.
    Author: Kimura E, Armelin HA.
    Journal: Arch Biol Med Exp; 1988 Dec; 21(3-4):435-41. PubMed ID: 2855698.
    Abstract:
    Even though the proto-oncogene c-Ki-ras is found to be amplified and overexpressed in the malignant Y-1 mouse corticoadrenal cell line, evidence for a causal relationship between c-Ki-ras overexpression and malignancy is still lacking. Such evidence is presented in this report. Amplified c-Ki-ras was found in both sublines of Y-1 cells that carry DM (double minute) or HSR (homogeneously stained region) chromosomes. Y-1 normal revertants did not display c-Ki-ras amplified sequences. Spontaneous retransformation of the normal revertants yielded anchorage-independent non-tumorigenic cells in which c-Ki-ras was not amplified. We propose that c-Ki-ras amplification is required to maintain the malignant state of Y-1 cells. Constitutive expression of poly A RNA homologous to viral sequences were detected in all sublines of Y-1 cells (malignant or normal revertants) by Northern hybridization using probes derived from the pFBJ-2 provirus. Rapid induction of c-fos proto-oncogene mRNA and late reduction in the levels of poly A+ viral transcripts resulted from ACTH treatment of Y-1 cells. However, ACTH treatment did not change c-Ki-ras mRNA levels.
    [Abstract] [Full Text] [Related] [New Search]